Hamid Mojibian

Prof. Hamid Mojibian


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2019 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
MQMichael Quail
Michael Quail
KGKarl Grunseich
Karl Grunseich
LBLauren A. Baldassarre
Lauren A. Baldassarre
HMHamid Mojibian
Hamid Mojibian
MMMark A. Marieb
Mark A. Marieb
DPDana C. Peters
Dana C. Peters
Left atrial (LA) late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is indicative of fibrosis, and has been correlated with reduced LA function, increased LA volume, and poor procedural outcomes in cohorts with atrial fibrillation (AF). However, the role of LGE as a prognostic biomarker for arrhythmia in cardiac disease has not been examined. In this study, we assessed LA LGE using a 3D LGE CMR sequence to examine its relationships with new onset atrial arrhythmia, and LA and left ventricular (LV) mechanical function. LA LGE images were acquired in 111 patients undergoing CMR imaging, including 66 patients with no prior history of an atrial arrhythmia. During the median follow-up of 2.7 years (interquartile range (IQR) 1.8–3.7 years), 15/66 (23%) of patients developed a new atrial arrhythmia. LA LGE ≥10% of LA myocardial volume was significantly associated with an increased rate of new-onset atrial arrhythmia, with a hazard ratio of 3.16 (95% CI 1.14–8.72), p = 0.026. There were significant relationships between LA LGE and both LA ejection fraction (r = − 0.39, p < 0.0005) and echocardiographic LV septal e’ (r = − 0.24, p = 0.04) and septal E/e’ (r = 0.31, p = 0.007). Elevated LA LGE is associated with reduced LA function and reduced LV diastolic function. LA LGE is associated with new onset atrial arrhythmia during follow-up.

30 September 2008 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
FSFelix J.V. Schlösser
Felix J.V. Schlösser
HMHamid Mojibian
Hamid Mojibian
HVHence J.M. Verhagen
Hence J.M. Verhagen
FMFrans L. Moll
Frans L. Moll
BMBart E. Muhs
Bart E. Muhs

1 January 2019 in EJVES Short Reports
Verified
Journal Article
Open access
Nariman NezamiNariman Nezami
Nariman Nezami
ILIgor Latich
Igor Latich
NMNikitha Murali
Nikitha Murali
RARahmat Ali
Rahmat Ali
BLBen A. Lin
Ben A. Lin
HMHamid Mojibian
Hamid Mojibian
Management of clot in transit in patients with pulmonary embolism, who are candidates for percutaneous intervention, can be challenging. This is a case report of simultaneous right atrial mechanical thrombectomy under echocardiography guidance and pulmonary artery embolectomy under fluoroscopy guidance, using the recently introduced FlowTriever system (Inari Medical Inc., Irvine, CA, USA). An 88 year old female, resuscitated from cardiopulmonary arrest near the end of a total right hip arthroplasty, presented for management of suspected massive pulmonary embolism. Her right atrial thrombus was removed under transthoracic echocardiography guidance, and her pulmonary arterial thrombus was subsequently successfully treated under fluoroscopy. The FlowTriever system can be safely and effectively used under real time transthoracic echocardiography guidance to retrieve clot in transit from the cardiac chambers, in addition to its standard application for the pulmonary artery under fluoroscopy guidance.

30 September 2008 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
PDF file
FSFelix J.V. Schlösser
Felix J.V. Schlösser
HMHamid Mojibian
Hamid Mojibian
ADAlan Dardik
Alan Dardik
HVHence J.M. Verhagen
Hence J.M. Verhagen
FMFrans L. Moll
Frans L. Moll
BMBart E. Muhs
Bart E. Muhs

22 February 2023 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
DDDavid Dexter
David Dexter
HKHerman Kado
Herman Kado
ASAbdullah Shaikh
Abdullah Shaikh
JSJonathan Schor
Jonathan Schor
SASuman Annambhotla
Suman Annambhotla
HMHamid Mojibian
Hamid Mojibian
We report in-hospital outcomes from the multicenter, prospective, single-arm ClotTriever Outcomes (CLOUT) registry, which enrolled up to 500 patients with proximal lower extremity deep vein thrombosis (DVT) treated with percutaneous mechanical thrombectomy using the ClotTriever System (Inari Medical). The CLOUT registry enrolled all-comer patients with DVT, irrespective of symptom duration, thrombus age, prior treatment of the current DVT, or bilateral thrombus. The primary effectiveness end point was defined as complete or near complete (≥75%) reduction in Marder score. Thrombus burden was assessed by an independent core laboratory. Mortality and serious adverse events, including device-relatedness, were adjudicated by an independent medical monitor. Here, safety and outcomes are evaluated through discharge. The median age was 61.9 years (IQR, 48.0-70.8), 50.5% were women, 24.9% had a history of DVT, and 23.2% had previously failed treatment of the current DVT. Nearly all procedures (99.4%) were performed in a single session with negligible procedural blood loss (median 40.0 mL; IQR, 20.0-50.0), and most patients (97.8%) required no subsequent intensive care unit monitoring. The primary effectiveness end point was achieved in 91.2% of limbs. Through discharge, 1 device-related serious adverse event (0.2%) occurred. Health status, as assessed by self-reported pain and circumferential measurements of limb edema, were significantly improved at discharge. Thrombectomy with the ClotTriever System is a safe and effective treatment for proximal lower extremity DVT, while also avoiding the need of intensive care. Early patient improvements are demonstrated, and follow-up is ongoing to 2 years.

10 March 2023 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
AFAttila Feher
Attila Feher
EMEdward J. Miller
Edward J. Miller
DPDana C. Peters
Dana C. Peters
HMHamid Mojibian
Hamid Mojibian
Albert SinusasAlbert Sinusas
Albert Sinusas
LBLauren A. Baldassarre
Lauren A. Baldassarre